The global hemodynamic monitoring market is experiencing significant growth, driven by the rising prevalence of cardiovascular diseases, an aging population, and increasing demand for minimally invasive monitoring technologies. Advancements in sensor technology, artificial intelligence, and non-invasive monitoring solutions are enhancing real-time patient assessment, improving clinical outcomes, and reducing hospital stays. North America leads the market due to high healthcare spending, technological advancements, and well-established healthcare infrastructure, while Asia-Pacific is emerging as a high-growth region due to increasing healthcare investments and expanding patient populations. Key players such as Edwards Lifesciences, Masimo, Getinge, Baxter, and Teleflex are driving market expansion through strategic acquisitions, product innovations, and collaborations. Overall, the market is expected to witness steady expansion, supported by increasing critical care needs and technological advancements in monitoring solutions.
Global Hemodynamic Monitoring Market is valued at USD 2.21 billion in 2023 and is expected to reach USD 3.83 by 2031, with a growing CAGR of 7.2% during the forecast period 2023 to 2030.
To know more, visit https://www.databridgemarketresearch.com/reports/global-hemodynamic-monitoring-market
Below are the Top Hemodynamic Monitoring Companies with a Significant Market Share:
|
Rank
|
Company
|
Overview
|
Product Portfolio
|
Sales Geographical Coverage
|
Developments
|
|
1.
|
Edwards Lifesciences Corporation.
|
Edwards Lifesciences specializes in medical technologies for structural heart disease and critical care monitoring. Their critical care segment offers advanced hemodynamic monitoring systems, including the Swan-Ganz pulmonary artery catheter and the HemoSphere advanced monitoring platform, which provide continuous and comprehensive hemodynamic assessments.
|
|
North America, Asia-Pacific, and Europe
|
In June 2024, Edwards Lifesciences announced the sale of its Critical Care product group to BD (Becton, Dickinson and Company) for $4.2 billion. This strategic move allows BD to enhance its portfolio with Edwards' advanced hemodynamic monitoring solutions, including technologies like the Swan-Ganz pulmonary artery catheter and the HemoSphere advanced monitoring platform. These products are designed to provide comprehensive pressure, flow, and tissue oximetry insights, aiding clinicians in managing patient perfusion effectively.
|
|
2.
|
Masimo.
|
Masimo is renowned for its innovative non-invasive monitoring technologies. In February 2021, Masimo expanded its hemodynamic monitoring portfolio by acquiring LiDCO, a company specializing in advanced hemodynamic monitoring equipment that measures cardiac output, stroke volume, and systemic vascular resistance.
|
|
North America, South America, Middle East and Africa, Asia-Pacific, and Europe
|
In November 2021, Masimo announced the launch of Dual SET Pulse Oximetry for a highly versatile patient monitoring and connectivity hub. The first application of Dual SET oximetry is an important step forward in Masimo SET-guided Critical Congenital Heart Disease (CCHD) screening with CE marking. This launch helped the company to expand its oximeter portfolio.
|
|
3.
|
Getinge AB
|
Getinge, a Swedish company, operates globally, providing a range of medical technology products. Through its Maquet brand, Getinge offers solutions in surgical workplaces, critical care, and cardiovascular segments. Maquet's product line includes advanced hemodynamic monitoring systems designed to support critical care and surgical procedures.
|
|
North America, South America, Latin America, Middle East and Africa, Asia-Pacific, and Europe
|
In July 2024, Getinge AB introduced Pulsiocare, an advanced hemodynamic monitoring platform designed to enhance patient care in intensive care units (ICUs) and operating rooms (ORs). Pulsiocare integrates Getinge's proven PiCCO and ProAQT technologies into a single, mobile monitor featuring a rechargeable battery and a responsive touchscreen interface. This system provides healthcare professionals with precise and continuous hemodynamic monitoring, facilitating informed decision-making for critically ill patients.
|
|
4.
|
Baxter.
|
Baxter International offers a diverse portfolio of medical products, including those for hemodynamic monitoring. In September 2019, Baxter enhanced its presence in the hemodynamic monitoring market by acquiring Cheetah Medical, a company known for its non-invasive hemodynamic monitoring technologies.
|
|
North America, South America, Middle East and Africa, Asia-Pacific, and Europe
|
In January 2023, Baxter International Inc., a leading global medical technology company, announced a comprehensive strategic action plan to improve operational efficiency, long-term performance, accelerate innovation, and create value for all stakeholders. These changes include a plan to create the company and its renal care and acute therapies business units (GBUs) into an independent, publicly traded company, simplified business, and manufacturing footprint to improve business performance, and other portfolios to improve Baxter’s capital structure, including a review of strategic options for the BioPharma Solutions (BPS) business.
|
|
5.
|
Teleflex Incorporated
|
Teleflex is a global provider of medical technologies. The company offers a range of hemodynamic monitoring solutions, including catheters and sensors designed for accurate and continuous assessment of cardiovascular function in critical care settings.
|
|
Americas, Middle East and Africa, Asia-Pacific, and Europe
|
In June 2023, Teleflex Incorporated, a leading global provider of medical technologies announced that it has signed two group purchase agreements with Premier, Inc. The new contracts, which came into force on 1 July 2023 allow Premier members to take advantage of special rates and terms at their discretion.
|
Conclusion
The global hemodynamic monitoring market is poised for sustained growth, fueled by technological advancements, increasing healthcare investments, and the rising prevalence of cardiovascular diseases. Market leaders like Edwards Lifesciences, Masimo, Getinge, Baxter, and Teleflex are continuously innovating to provide more accurate, non-invasive, and AI-driven monitoring solutions, improving patient care and clinical efficiency. While North America remains dominant due to its strong healthcare infrastructure, emerging markets in Asia-Pacific present lucrative opportunities for expansion. As healthcare systems worldwide prioritize early diagnosis and critical care management, the hemodynamic monitoring market will continue to evolve, offering new opportunities for growth and innovation.
